All news from Thoracic Medicine

Digital Intervention: Asthma Control And Medication Adherence

Although inhaled corticosteroids (ICS) are well-established as the cornerstone of asthma treatment patient adherence has been consistently shown to be suboptimal. In a 2015 systematic review published in  Respiratory Care, the mean level of ICS adherence ranged from 22% to 63% across the studies included, and poor adherence led to 24% and 60% of exacerbations and asthma-related hospitalizations, respectively.

Web-Based Monitoring: Improved Lung Cancer Survival

After treatment for lung cancer, web-based monitoring of patient-reported outcomes is associated with improved overall survival, according to final results from a randomized trial. "Electronic patient-reported symptom monitoring should be considered for patients with lung cancer who have received treatment as a part of high-quality cancer care," Dr. Fabrice Denis from Institut Inter-regional de Cancerologie Jean-Bernard, Le Mans, France told Reuters Health. 

Obsessive Compulsive May Mental Illness In Youth

Obsessive-compulsive symptoms (OCS) in youth may be an early warning sign for subsequent mental illness, including psychosis, new research suggests. Investigators analyzed data from the Philadelphia Neurodevelopmental Cohort (PNC), consisting of over 7000 youngsters ranging in age from 11 to 21 years. Participants, who were not seekers of mental health services, were screened for OCS as well as other psychiatric disorders.

Detection Of Common Sexually Transmitted Infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI). This newest Aptima assay joins a growing suite of market-leading tests offered by Hologic to help combat the rise of STIs in the U.S.

Ramifications Of Low DHA Levels Among pregnant women

A new scientific paper has, for the first time, proposed an omega-3 DHA target blood level of 5% or higher for pregnant women who want to reduce their risk of preterm birth. Published in the December edition of Nutrients, authors Kristina Harris Jackson, Ph.D., RD, and William S. Harris, Ph.D., discuss the ramifications of low DHA levels among pregnant women.